Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 1, 2024
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
[ Tue, Oct 01st 2024
] - WOPRAI
Raghuram Selvaraju Reiterated (VRNA) at Strong Buy and Held Target at $36 on, Oct 1st, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Verona Pharma plc" (VRNA) at Strong Buy and Held Target at $36 on, Oct 1st, 2024.
Raghuram has made no other calls on VRNA in the last 4 months.
There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $37 on, Monday, July 22nd, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $38 on, Friday, June 28th, 2024
